AnalystsMichael DiFioreMichael DiFiore's Stock Forecasts
AnalystsMichael DiFiore
Sectors:
Industries:
Analyst Ranking
Bottom 22%
#4314 out of 5500 analysts
Average Return
-12.49%
Win Rate
33%1 out of 3
Risk vs Reward
Poor
Good
Michael DiFiore's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cincor Pharma IncCINC | +52.26% | $19.00 | $28.93 | 2022-02-01 - 2023-01-31 | Buy |
Michael DiFiore Analyst Color
Get additional color on Michael DiFiore's coverage of popular stocks
Michael DiFiore's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Vtv Therapeutics IncVTVT | 1 | Buy | $44.00 | +35.97% | Initiates Coverage On | 6 months ago |
Skye Bioscience IncSKYE | 1 | Buy | $80.00 | N/A | Initiates Coverage On | a year ago |
Atara Biotherapeutics IncATRA | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Cincor Pharma IncCINC | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.